DRUG · Unmapped registry intervention
nab-Paclitaxel
Find medicine records ·
Find other trials using this name
Clinical trial
Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)
NCT01583426
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Paclitaxel
Normalized identity: paclitaxelView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedNanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Tubular Breast Cancer Stage IIunresolved
Mucinous Breast Cancer Stage IIunresolved
Breast Cancer Female NOSunresolved
Invasive Ductal Breast Cancerunresolved
Tubular Breast Cancer Stage IIIunresolved
HER-2 Positive Breast Cancerunresolved
Inflammatory Breast Cancer Stage IVunresolved
Interventions
nab-PaclitaxelDRUG
PaclitaxelDRUG · verified · RxNorm: paclitaxel
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01583426 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.